Electrical stimulation-induced release of β-endorphin from genetically modified neuro-2a cells

Cell Transplantation

Volumn 17, Issue 5, 2008, Pages 543-548

  Storn, Volker ^a,c   Kirschbaum, Michael ^a,b,d   Schlosshauer, Burkhard ^a   Mack, Andreas F ^b   Fricke, Cornelia ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d FRAUNHOFER INSTITUTE FOR BIOMEDICAL ENGINEERING   (Germany)

Author keywords

Electrical stimulation of secretion; Endorphin; Genetically engineered cells; Neuro 2a; Pain; Regulated secretory pathway

Indexed keywords

BETA ENDORPHIN; GENE PRODUCT; PROOPIOMELANOCORTIN;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN NEURO 2A; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA MODIFICATION; ELECTRIC FIELD; ELECTROSTIMULATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC ENGINEERING; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; REGULATORY MECHANISM; SECRETORY GRANULE; TECHNIQUE;

EID: 51749124489     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908785095999     Document Type: Article

References (21)

1. Assadi, M.; Sharpe, J. C.; Snell, C.; Loh, Y. P. The C-terminus of prohormone convertase 2 is sufficient and necessary for Raft association and sorting to the regulated secretory pathway. Biochemistry 43:7798-7807; 2004.
2. Balkowiec, A.; Katz, D. M. Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ. J. Neurosci. 20:7417-7423; 2000.
3. Bent, S.; Saint, S.; Vittinghoff, E.; Grady, D. Antibiotics in acute bronchitis: A meta-analysis. Am. J. Med. 107:62-67; 1999.
4. Bes, J. C.; Tkaczuk, J.; Czech, K. A.; Tafani, M.; Bastide, R.; Caratero, C.; Pappas, G. D.; Lazorthes, Y. One-year chromaffin cell allograft survival in cancer patients with chronic pain: Morphological and functional evidence. Cell Transplant. 7:227-238; 1998.
5. Ishii, K.; Isono, M.; Inoue, R.; Hori, S. Attempted gene therapy for intractable pain: Dexamethasone-mediated exogenous control of beta-endorphin secretion in genetically modified cells and intrathecal transplantation. Exp. Neurol. 166:90-98; 2000.
6. Lazorthes, Y.; Sagen, J.; Sallerin, B.; Tkaczuk, J.; Duplan, H.; Sol, J. C.; Tafani, M.; Bes, J. C. Human chromaffin cell graft into the CSF for cancer pain management: A prospective phase II clinical study. Pain 87:19-32; 2000.
7. LeSage, M. G.; Gustaf, E.; Dufek, M. B.; Pentel, P. R. Effects of maternal intravenous nicotine administration on locomotor behavior in pre-weanling rats. Pharmacol. Biochem. Behav. 85:575-583; 2006.
8. Lin, C. R.; Yang, L. C.; Lee, T. H.; Lee, C. T.; Huang, H. T.; Sun, W. Z.; Cheng, J. T. Electroporation-mediated pain-killer gene therapy for mononeuropathic rats. Gene Ther. 9:1247-1253; 2002.
9. MacLeod, S. L.; Chowdhury, P. The genetics of nicotine dependence: Relationship to pancreatic cancer. World J. Gastroenterol. 12:7433-7439; 2006.
10. Noel, G.; Zollinger, L.; Laliberte, F.; Rassart, E.; Crine, P.; Boileau, G. Targeting and processing of pro-opiomelanocortin in neuronal cell lines. J. Neurochem. 52:1050-1057; 1989.
11. Pappas, G. D.; Lazorthes, Y.; Bes, J. C.; Tafani, M.; Winnie, A. P. Relief of intractable cancer pain by human chromaffin cell transplants: Experience at two medical centers. Neurol. Res. 19:71-77; 1997.
12. Sagen, J.; Wang, H.; Tresco, P. A.; Aebischer, P. Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances. J. Neurosci. 13:2415-2423; 1993.
13. Saitoh, Y.; Eguchi, Y.; Hagihara, Y.; Arita, N.; Watahiki, M.; Tsujimoto, Y.; Hayakawa, T. Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated Tet-on proopiomelanocortin Neuro2A cells in the subarachnoid space. Hum. Gene Ther. 9:997-1002; 1998.
14. Saitoh, Y.; Taki, T.; Arita, N.; Ohnishi, T.; Hayakawa, T. Analgesia induced by transplantation of encapsulated tumor cells secreting beta-endorphin. J. Neurosurg. 82:630-634; 1995.
15. Segal, R.; Stacey, B. R.; Rudy, T. E.; Baser, S.; Markham, J. Spinal cord stimulation revisited. Neurol. Res. 20:391-396; 1998.
16. Vardy, J.; Chiew, K. S.; Galica, J.; Pond, G. R.; Tannock, I. F. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br. J. Cancer 94:1011-1015; 2006.
17. Wu, C. M.; Lin, M. W.; Cheng, J. T.; Wang, Y. M.; Huang, Y. W.; Sun, W. Z.; Lin, C. R. Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats. Gene Ther. 11:933-940; 2004.
18. Yaksh, T. L.; Gross, K. E.; Li, C. H. Studies on the intrathecal effect of beta-endorphin in primate. Brain Res. 241:261-269; 1982.
19. Yasothornsrikul, S.; Greenbaum, D.; Medzihradszky, K. F.; Toneff, T.; Bundey, R.; Miller, R.; Schilling, B.; Petermann, I.; Dehnert, J.; Logvinova, A.; Goldsmith, P.; Neveu, J. M.; Lane, W. S.; Gibson, B.; Reinheckel, T.; Peters, C.; Bogyo, M.; Hook, V. Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc. Natl. Acad. Sci. USA 100:9590-9595; 2003.
20. Young, R. F.; Brechner, T. Electrical stimulation of the brain for relief of intractable pain due to cancer. Cancer 57:1266-1272; 1986.
21. Zhang, C. F.; Dhanvantari, S.; Lou, H.; Loh, Y. P. Sorting of carboxypeptidase E to the regulated secretory pathway requires interaction of its transmembrane domain with lipid rafts. Biochem. J. 369:453-460; 2003.